Management of Patients With Female Reproductive Disorders
Management of Patients With Female Reproductive Disorders
Management of Patients With Female Reproductive Disorders
• Common problem.
• Vagina is normally protected by acid pH maintained, in
part, by Lactobacillus acidophilus.
• Vaginal epithelium is responsive to estrogen, which
induces glycogen formation, which breaks down into
lactic acid; therefore decreased estrogen decreases acid
production.
• With perimenopause and menopause, decreased
estrogen is related to vaginal and labial atrophy, and
tissue is more susceptible to infection.
• Candidiasis
• Gardnerella
• Trichomonas vaginalis
• Bartholinitis
• Cervicitis
• Atrophic vaginitis
• Discomfort
• Anxiety
• Risk for infection or spread of infection
• Deficient knowledge
False
• No cure
• Antiviral agents acyclovir (Zovirax) valacyclovir (Valtrex),
and famiciclovir (Famvir) can suppress symptoms
• Recurrences may be associated with stress, sunburn,
dental work, inadequate rest, and inadequate nutrition
• Risk for infants delivered vaginally to become infected;
therefore cesarean delivery may be performed
• Health history
• Pelvic Examination
• Assess for risk factors for STDs
• Acute pain
• Risk for infection
• Risk for spread of infection
• Anxiety
• Deficient knowledge
False
• History
• Physical and pelvic exam
• Psychosocial and emotional responses
• Patient knowledge
• Anxiety
• Disturbed body image
• Acute pain
• Deficient knowledge
• Hemorrhage
• DVT
• Bladder dysfunction
• Usually administered IV
• Patients undergoing chemotherapy need specific care to
address the side effects and complications of the
chemotherapy agent or agents administered. Side effects
may include neutropenia, thromobocytopenia,
nephrotoxicity, neurotoxicity, hair loss, hypersensitivity
reactions, nausea, and vomiting
• Paclitaxil (Taxol)
• Carboplatin (paraplatin)
• Liposomal therapy
• Foley catheter
• Absolute bed rest, positioning restrictions
• Diet: low residue
• Hygiene
• Monitoring of patient
• Side effects of therapy
• Emotional support of patient
• Address potential for isolation
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins
Safety (Intracavity Radiation)